Response to: 'Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist' by Cherqaoui et al

Nadia Bonekamp, Roberta Caorsi, Joost Frenkel, Marco Gattorno

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)e89
JournalAnnals of the Rheumatic Diseases
Volume77
Issue number12
DOIs
Publication statusPublished - Dec 2018

Cite this